← Back to Stock Screener← Stock Screener

ZYBERNO

Stock Report

Updated Aug 24, 2026

PROCYON CORPORATION (PCYN)

Healthcare • OTC

Professional Investment Analysis

ZYBERNO SCORE →

Is it a great business? Is it getting better?

22.0/100

POOR BUSINESS

PROCYON CORPORATION (PCYN) scores 22/100 — concerning metrics indicating significant structural or financial risks.

📊 How is the Zyberno Score calculated? +

The Zyberno Score answers one question: "Is this a quality business worth owning?" It's a 0-100 investment grade that evaluates business fundamentals across four critical dimensions, based on principles from Warren Buffett, Benjamin Graham, Peter Lynch, and Charlie Munger.

The 4 Core Categories (25 points each):

1. PROFITABILITY (25 pts)

Metrics: ROE, ROIC, Net Margin, Operating Margin
Thresholds: ROE >20% excellent • ROIC >20% excellent • Net Margin >20% excellent • Operating Margin >25% excellent

2. FINANCIAL STRENGTH (25 pts)

Metrics: Debt-to-Equity, Current Ratio, Interest Coverage, Altman Z-Score
Thresholds: D/E <0.3 excellent • Current Ratio >2.5 excellent • Interest Coverage >10x excellent • Altman Z >3.0 safe

3. CASH FLOW QUALITY (25 pts)

Metrics: Free Cash Flow, OCF vs Net Income, FCF Margin
Thresholds: Positive & growing FCF excellent • OCF/NI >1.2x excellent (cash earnings exceed accounting)

4. GROWTH & CONSISTENCY (25 pts)

Metrics: Revenue Growth, Net Income Growth, FCF Growth, Piotroski F-Score
Thresholds: Growth via log-linear regression • Piotroski 8-9 excellent, 6-7 good

Score Interpretation:

75-100

GREAT BUSINESS

65-74

GOOD BUSINESS

50-64

AVERAGE BUSINESS

30-49

WEAK BUSINESS

0-29

POOR BUSINESS

→ View full PCYN quality analysis & detailed breakdown

VALUATION SIGNAL

N/A (Requires more data)

Requires fair value calculation and current price data

💰 How is Margin of Safety calculated? +

Margin of Safety measures how much discount or premium you're paying relative to a stock's intrinsic value. It's Benjamin Graham's core principle: the larger the margin, the lower your downside risk.

Formula: (Intrinsic Value − Current Price) ÷ Intrinsic Value × 100%

How We Calculate Intrinsic Value (DCF Method):

Step 1: Calculate current Owner Earnings (OCF − Maintenance CapEx)

Step 2: Calculate company-specific growth rate using log-linear regression on 16 quarters of Owner Earnings

Step 3: Project 10 years forward using the calculated growth rate

Step 4: Discount each year's cash flow to present value using 10% discount rate

Step 5: Calculate terminal value using 3% perpetual growth rate

Step 6: Sum all discounted cash flows = Intrinsic Value

What The Percentages Mean:

+50% or more

EXCELLENT — Very undervalued

+25% to +50%

GOOD — Attractive discount

0% to +25%

FAIR — Reasonable value

0% to -25%

CAUTION — Slight premium

-25% or worse

POOR — Overvalued

"Price is what you pay, value is what you get." — Warren Buffett

→ View full PCYN valuation analysis · → View full PCYN Brina Gap analysis

📈 How is Brina Gap calculated? +

Brina Gap measures the difference between the growth a business can fundamentally sustain and the growth the market is already pricing in.

Formula: Fundamental Growth Rate − Market-Implied Growth Rate

The Two Components:

Fundamental Growth Rate = ROIC × Reinvestment Rate

What the business can sustainably grow at based on how much it reinvests and what return it earns on that capital. Grounded in historical financials.

Market-Implied Growth Rate = Reverse DCF

The growth rate the current Enterprise Value implicitly assumes. Calculated by back-solving a 10-year DCF model (10% WACC, 3% terminal growth) until the present value of projected cash flows equals EV.

What The Gap Means:

Gap > +5% Market Underestimates — potential upside

+2% to +5% Slight Underestimate

-2% to +2% Fairly Priced — market consensus matches fundamentals

-5% to -2% Slight Overestimate

Gap < -5% Market Overestimates — price embeds optimism fundamentals don't support

A positive gap (market underestimates) combined with a positive Margin of Safety is the strongest combined signal — the business is both cheap historically and forward economics are stronger than the price suggests.

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-14.4%)

Debt-to-Equity (Solvency Risk):EXCELLENT (0.28x)

Operating Margin (Operational Efficiency):CRITICAL (-4.6%)

Return on Capital (Capital Efficiency):CRITICAL (-7.6%)

📊 Valuation Trilogy

Three interconnected metrics for complete valuation analysis

Click any metric for full methodology and detailed analysis

Zyberno's Verdict

PROCYON CORPORATION (PCYN) stock report — Zyberno Score 22/100 (POOR BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, PCYN generated -$90.91K in Owner Earnings. Capital was deployed as follows: $63.91K invested in capital expenditures.

DIVISION I: EXECUTIVE SUMMARY

A. Market Valuation

Market Price & Capitalization (1)

Market Cap:$2.03M

Valuation Multiples (3)

P/B Ratio:0.89x

P/S Ratio:0.41x

Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$2.02M

Price Action & Momentum (3)

12-1 Momentum:

+36.8% (47th pctile)

📈 Click to view full PCYN Momentum analysis →

Momentum Percentile:47 / 100

% of 52-Week High:89.3%

B. Profitability Assessment

Return Metrics (3)

ROE:

-14.4%

📊 Click to view full PCYN ROE analysis →

ROA:-10.5%

Roic:

-7.6%

📊 Click to view full PCYN ROIC analysis →

Margin Analysis (3)

Operating Margin Ttm:-4.6%

Net Margin Ttm:-6.8%

Ebitda Margin:-3.0%

TTM Performance (3)

Gross Margin Ttm:78.1%

Operating Margin Ttm:-4.6%

Net Margin Ttm:-6.8%

Yield Metrics (2)

Earnings Yield:-$19.90

Dividend Yield:0.0%

C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

Earnings Surprise (SUE):

-0.37

📊 Click to view full PCYN Earnings Surprise analysis →

EPS Surprise vs Expected:-700.0%

Latest Earnings Filed:2024-05-24

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):3.6%

Earnings Growth (Linear) (1)

Net Income Growth Rate (Linear):-40.3%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):-34.7%

Operating Cash Flow Growth Rate (Linear):-35.5%

Operating Growth (Linear) (1)

Operating Income Growth Rate (Linear):-25.9%

D. Financial Stability

Liquidity Ratios (3)

Current Ratio:3.08x

Quick Ratio:2.41x

Cash Ratio:0.42x

Leverage Analysis (3)

Debt To Equity Ttm:0.28x

Debt-to-Equity Ratio:0.28x

Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:1,596,651.00

Cash And Cash Equivalents:326,143.00

Long Term Debt:$139.21K

Net Debt:-$6.27K

DIVISION II: FINANCIAL STATEMENTS ANALYSIS

A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $4.98M

Linear Growth: 3.6%

📊 Click to view full PCYN Revenue analysis & methodology →

Cost Of Revenue Ttm:$1.09M

Profitability Breakdown (2)

Gross profit TTM: $3.89M

Linear Growth: 5.3%

📊 Click to view full PCYN Gross Profit analysis & methodology →

Operating income TTM: -$231.71K

Linear Growth: -25.9%

📊 Click to view full PCYN Operating Income analysis & methodology →

Bottom Line Performance (3)

Net income TTM: -$341.14K

Linear Growth: -40.3%

📊 Click to view full PCYN Net Income analysis & methodology →

Income Before Tax:-$301.94K

Ebitda Ttm:-150,004.00

Operating Expenses (5)

Operating Expenses:4,123,140.00

R And D Expense:30,100.00

Sga Expense:2,037,931.00

Income Tax Expense:$315.53K

Interest Expense:0.00

Expense Ratios (3)

R And D To Revenue Percentage:2.1%

Sga To Revenue Percentage:144.3%

Ebitda Margin:-3.0%

B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$3.20M

Current Assets:$2.37M

Ppe Net:262,020.00

Goodwill:0.00

Intangible Assets:$17.00K

Liability Structure (4)

Total Liabilities:917,122.00

Current Liabilities:769,234.00

Long Term Debt:$139.21K

Short Term Debt:$180.67K

Equity & Capital (3)

Equity:$2.29M

Retained Earnings:-$2.33M

Common Stock:80,000,000.00

Working Capital Items (3)

Accounts Receivable:512,909.00

Inventory:510,006.00

Accounts Payable:160,922.00

Special Items (2)

Contract Liabilities:0.00

Stock Based Compensation:7,705.00

C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: -$61.25K

Linear Growth: -35.5%

Free cash flow TTM: -$125.16K

Linear Growth: -34.7%

📊 Click to view full PCYN Free Cash Flow analysis & methodology →

Investment Activities (2)

Investing Cash Flow:-$1.63K

Capital Expenditures Ttm:63,912.00

Financing Activities (3)

Financing Cash Flow:$0.00

Dividends Paid Ttm:0.00

Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00

Long Term Debt Issuance:$0.00

Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:81,701.00

DIVISION III: OPERATIONAL METRICS

A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.04

Eps diluted TTM: -$0.04

Linear Growth: 100.0%

📊 Click to view full PCYN EPS analysis & methodology →

Earnings Per Share Ttm:-$0.04

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.61

Operating Cash Flow Per Share:-$0.01

Book Value & Capital (2)

Book Value Per Share:$0.28

Cash Per Share:0.04

Dividend Policy (1)

Dividend Payout Ratio:-999.00x

B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:1.53x

Working Capital Turnover Ttm:3.12x

Receivables Management (2)

Receivables Turnover Ttm:9.72x

Days Sales Outstanding Ttm:37.56

Inventory Management (2)

Inventory Turnover Ttm:2.14x

Days Inventory Outstanding Ttm:170.31

Payables & Cash Cycle (2)

Days Payable Outstanding:53.74

Cash Conversion Cycle:154.13

C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00

Quality Score:40.00

Market Metrics (2)

Beta:0.00x

Volatility Category:unknown

DIVISION IV: INVESTMENT ANALYSIS

A. Value Investment Framework

Owner Earnings Analysis (1)

-$90.91K

B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (3)

Revenue Growth Rate (Linear):3.6%

Net Income Growth Rate (Linear):-40.3%

Operating Income Growth Rate (Linear):-25.9%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):-34.7%

Operating Cash Flow Growth Rate (Linear):-35.5%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):5.3%

Book Value Growth Rate (Linear):2.4%

C. Company Profile & Context

Corporate Information (6)

Symbol:PCYN

Company Name:PROCYON CORPORATION

Sector:Healthcare

Industry:Pharmaceuticals

Exchange:OTC

Country:Unknown

Market Classification (3)

Market Cap Category:N/A

Price Category:penny

Volume Category:N/A

Share Structure (3)

Shares Outstanding:8.12M

Shares Outstanding Basic:8.12M

Shares Outstanding Diluted:8.12M

Data Processing Info (3)

Processing Version:v3.0

Last Updated:2026-08-24 17:01:24 UTC

Data Timestamp:2026-06-24T16:51:03.333243